FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On April 27, 2007
Docket # Title
1999P-0033 Combat the spread of transmissible spongiform encephalopathy
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003N-0573 Draft Animal Cloning Risk Assessment
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
2005N-0272 Irradiation in the Production, Processing, and Handling of Food
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2005P-0459 To enforce ban on carbon monoxide gas in fresh meat packaging
2006D-0441 Guidance for Industry: Protocols for the Conduct of Method Transfer Studies for Type C Medicated Feed Assay Methods
2006N-0416 Use of Ozone-Depleting Substances; Removal of Essential Use Designations
2006P-0394 Revise the labeling requirements for eggs sold in the United States
2006P-0450 Revoke approval of Allergan's supplemental NDA #21-257/S-013 for Lumigan (bimatoprost ophthalmic solution 0.03%) and deny Alcon's supplemental NDA for Travatan (travopr
2006P-0523 Require ANDA applicant for generic of Eloxatin solution as reference drug to perform clinical testing
2007D-0122 Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Computerized Labor Monitoring Systems
2007N-0018 Agency Information Collection Activities; Proposed Collection; Comment Request; Human Cells, Tissues, and Cellular and Tissue-Based Products: Establishment Registration and Listing; Form FDA 3356; El
2007N-0068 Medical Device User Fee and Modernization Act: Public Meeting
2007N-0120 Medical Devices; Obstetrical and Gynecological Devices; Classification of Computerized Labor Monitoring System
2007N-0121 Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
2007P-0044 Ban Third Generation Oral Contraceptives Containing Desogestrel Due to Increased Risk of Venous Thrombosis
2007P-0085 Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
2007P-0149 Canned Pacific Salmon Deviating From Identity Standard; Temporary Permit for Market Testing
2007P-0150 Iceberg Water Deviating From Identity Standard; Temporary Permit for Market Testing
1999P-0033 Combat the spread of transmissible spongiform encephalopathy
EMC 15 Form Letters (1) Vol #: 11
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
C 1414 L Lipman Vol #: 262
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 1480 J. Sequeira Vol #: 12
2003N-0573 Draft Animal Cloning Risk Assessment
EMC 352 J. Burley Vol #: 5
EMC 353 J. Stockman Vol #: 5
EMC 354 J. Stockman Vol #: 5
EMC 355 B. Lugaresi Vol #: 5
EMC 356 K. Lintner Vol #: 5
EMC 357 B. Dively Vol #: 5
EMC 358 I. Price Vol #: 5
EMC 359 J. Mueller Vol #: 5
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
MO 25 TMJ Implants, Inc, and Robert W. Christensen, and Maureen K Mooney Vol #: 240
MO 26 TMJ Implants, Inc, and Robert W. Christensen, and Maureen K Mooney Vol #: 240
2005N-0272 Irradiation in the Production, Processing, and Handling of Food
EREG 591 D. Witmer Vol #: 4
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
EMC 593 M. Wolfe Vol #: 12
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
EMC 4375 D. Davis Vol #: 199
EMC 4376 S. McClellan Vol #: 199
EMC 4377 C. Kirts Vol #: 199
EMC 4378 C. Wyatt Vol #: 199
EMC 4379 L. Wavrin Vol #: 199
EMC 4380 D. Baker Vol #: 199
EMC 4381 P. Russen Vol #: 199
EMC 4382 K. Prewitt Vol #: 199
EMC 4383 D. DePoyster Vol #: 199
EMC 4384 J. Edmonds Vol #: 199
2005P-0459 To enforce ban on carbon monoxide gas in fresh meat packaging
SUP 2 American Meat Institute (AMI) Vol #: 7
2006D-0441 Guidance for Industry: Protocols for the Conduct of Method Transfer Studies for Type C Medicated Feed Assay Methods
GDL 2 Guidance Vol #: 2
NAD 2 FDA Vol #: 1
2006N-0416 Use of Ozone-Depleting Substances; Removal of Essential Use Designations
NFR 2 FDA Vol #: 1
2006P-0394 Revise the labeling requirements for eggs sold in the United States
C 89 K Elgin Vol #: 7
2006P-0450 Revoke approval of Allergan's supplemental NDA #21-257/S-013 for Lumigan (bimatoprost ophthalmic solution 0.03%) and deny Alcon's supplemental NDA for Travatan (travopr
RC 1 Pfizer Inc Vol #: 1
2006P-0523 Require ANDA applicant for generic of Eloxatin solution as reference drug to perform clinical testing
SUP 1 Sanofi-aventis U.S LLC Vol #: 2
2007D-0122 Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Computerized Labor Monitoring Systems
NAD 1 FDA Vol #: 1
2007N-0018 Agency Information Collection Activities; Proposed Collection; Comment Request; Human Cells, Tissues, and Cellular and Tissue-Based Products: Establishment Registration and Listing; Form FDA 3356; El
N 2 FDA Vol #: 1
2007N-0068 Medical Device User Fee and Modernization Act: Public Meeting
NCR 1 FDA Vol #: 1
2007N-0120 Medical Devices; Obstetrical and Gynecological Devices; Classification of Computerized Labor Monitoring System
CP 1 Barnev Ltd. Vol #: 1
NFR 1 FDA Vol #: 1
2007N-0121 Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
EAPE 110 McEvoy, Gerald Vol #: 1
EAPE 111 Mentari, Evelyn Vol #: 1
EAPE 112 madani, soraya Vol #: 1
EAPE 113 madani, soraya Vol #: 1
EAPE 114 Korab, Darlene Vol #: 1
EAPE 115 Korab, Darlene Vol #: 1
EAPE 116 Grijalva, Juan Carlos Vol #: 1
EMC 3 J. Ellis Vol #: 2
EMC 4 S. Harley Vol #: 2
2007P-0044 Ban Third Generation Oral Contraceptives Containing Desogestrel Due to Increased Risk of Venous Thrombosis
EMC 184 Form Letters (1) Vol #: 6
2007P-0085 Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
EMC 65 C. Sims Vol #: 4
EMC 66 P. Hoage Vol #: 4
EMC 67 D. Gabe Vol #: 4
EMC 68 A. & C. Hile Vol #: 4
EMC 69 M. Butler Vol #: 4
EMC 70 J. Dickey Vol #: 4
EMC 71 C. Wilson Vol #: 4
EMC 72 D. Johnson Vol #: 4
EMC 73 J. Boyle Vol #: 4
EMC 74 C. Giordano Vol #: 4
EMC 75 M. Nicholl Vol #: 4
EMC 76 J. Walden Vol #: 4
EMC 77 J. Walden Vol #: 4
EMC 78 J. Walden Vol #: 4
EMC 79 J. Walden Vol #: 4
EMC 80 J. Walden Vol #: 4
EMC 81 J. Walden Vol #: 4
EMC 82 R. Berkey Vol #: 4
EMC 83 M. Ferguson Vol #: 4
EMC 84 A. Rodgers Vol #: 4
EMC 85 P. Turkle Vol #: 4
EMC 86 T. Chiu Vol #: 4
EMC 87 J. Chan Vol #: 4
EMC 88 D. Bachelder Vol #: 4
2007P-0149 Canned Pacific Salmon Deviating From Identity Standard; Temporary Permit for Market Testing
NTP 1 FDA Vol #: 1
2007P-0150 Iceberg Water Deviating From Identity Standard; Temporary Permit for Market Testing
NTP 1 FDA Vol #: 1

Page created on April 27, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management